(EMAILWIRE.COM, December 27, 2017 ) The Latin America Intrauterine devices (IUD’S) Market was worth $ 238 million in 2016 and estimated to reach $ 301 million by the end of 2021 with a growing potential of 4.8 %.

Intrauterine devices (IUDs) are contraceptive medical implants used to avert pregnancies for a long time period. The intrauterine contraceptive device is a safe, effective and convenient contraceptive method. Their use in less developed countries has been controlled due to increase in menstrual blood loss, a vital issue in populations with a high prevalence of anaemia. The levonorgestrel releasing IUD (LNg IUD) which is the first device that is highly effective, long-lasting and reduces the blood loss during menstruation. So, this device is accepted, most used in Latin America. This device will have a clear niche amid reversible contraceptives when available.

Full report at: http://www.marketdataforecast.com/market-reports/latin-america-intrauterine-devices-market-1096/

Technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), direct health benefits other than birth control, increasing government initiatives to prevent unwanted abortions and pregnancies are driving the growth of the market in Latin America. The factors that are hampering the growth of the market are issues of Infertility, Religious and cultural opposition, ectopic pregnancy, pelvic inflammatory infection, and Limited access to contraception.

The Latin America intrauterine Devices market is broadly categorized based on product type into Hormonal intrauterine device and Copper intrauterine device. The largest share in the market is held by Hormonal IUD’S compared to Copper IUD’S due to their less risks and complications.

Request sample: http://www.marketdataforecast.com/market-reports/latin-america-intrauterine-devices-market-1096/request-sample

Key players influencing the Latin America intrauterine devices market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer AG, Teva Pharmaceutical, Pfizer, Mylan laboratories, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc.

About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results